Photorefractive keratectomy versus laser in situ keratomileusis for the treatment of spherical hyperopia
- PMID: 12769154
- DOI: 10.1097/00140068-200301000-00009
Photorefractive keratectomy versus laser in situ keratomileusis for the treatment of spherical hyperopia
Abstract
Objective: To compare photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in treating spherical hyperopia using the VISX STAR S2 excimer laser.
Intervention: Fifteen consecutive eyes of 15 patients underwent PRK, and 16 consecutive eyes of 16 patients underwent LASIK (follow-up: 12 months).
Main outcome measures: Postoperative pain, uncorrected visual acuity (UCVA), deviation from intended correction, and loss of best spectacle-corrected visual acuity (BSCVA).
Results: Mean preoperative spherical equivalent was + 2.18 diopter [D] for PRK and + 2.03D for LASIK. All PRK patients experienced significant postoperative pain that required systemic medication, whereas LASIK patients had minor and transient discomfort. Mean deviation from intended correction was -0.83D, + 0.01D, and + 0.18D at 1, 6, and 12 months after PRK, and + 0.22D, +0.30D, and + 0.40D at 1, 6, and 12 months after LASIK (P = 0.002 at 1 month). A higher proportion of LASIK eyes had a UCVA of 20/20 or better at all time points (P = 0.013 and 0.025 at 1 and 3 months, respectively). There was no statistically significant difference between both groups in BSCVA loss.
Conclusions: LASIK and PRK are comparable in efficacy and safety. However, PRK was more painful, with an initial and temporary myopic over-correction that did not occur after LASIK. Stability was achieved between 3 and 6 months following PRK, and one month following LASIK.
Similar articles
-
Meta-analysis: clinical outcomes of laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) in hyperopia.BMC Ophthalmol. 2025 Mar 18;25(1):140. doi: 10.1186/s12886-025-03956-6. BMC Ophthalmol. 2025. PMID: 40102791 Free PMC article.
-
Excimer laser treatment of spherical hyperopia: PRK or LASIK?Trans Am Ophthalmol Soc. 2000;98:59-66; discussion 66-9. Trans Am Ophthalmol Soc. 2000. PMID: 11190041 Free PMC article.
-
Comparison of photorefractive keratectomy and laser in situ keratomileusis for the treatment of compound hyperopic astigmatism.J Cataract Refract Surg. 2003 May;29(5):900-7. doi: 10.1016/s0886-3350(02)02039-4. J Cataract Refract Surg. 2003. PMID: 12781273 Clinical Trial.
-
Laser-assisted subepithelial keratectomy and photorefractive keratectomy for the correction of hyperopia. Results of a 2-year follow-up.J Cataract Refract Surg. 2003 Nov;29(11):2105-14. doi: 10.1016/s0886-3350(03)00415-2. J Cataract Refract Surg. 2003. PMID: 14670418 Clinical Trial.
-
Evidence for superior efficacy and safety of LASIK over photorefractive keratectomy for correction of myopia.Ophthalmology. 2006 Nov;113(11):1897-908. doi: 10.1016/j.ophtha.2006.08.013. Ophthalmology. 2006. PMID: 17074559
Cited by
-
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD007112. doi: 10.1002/14651858.CD007112.pub3. Cochrane Database Syst Rev. 2012. PMID: 22696365 Free PMC article.
-
Five year follow up of laser in situ keratomileusis for all levels of myopia.Br J Ophthalmol. 2006 Jan;90(1):20-3. doi: 10.1136/bjo.2005.075127. Br J Ophthalmol. 2006. PMID: 16361660 Free PMC article.
-
Meta-analysis: clinical outcomes of laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) in hyperopia.BMC Ophthalmol. 2025 Mar 18;25(1):140. doi: 10.1186/s12886-025-03956-6. BMC Ophthalmol. 2025. PMID: 40102791 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources